Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sechang Zhixie Powder is a traditional Chinese medicine (TCM) formulation with a long history of use among the Yi people in Yunnan, China for the treatment of pediatric diarrhea. The formula is composed primarily of herbal ingredients such as Rodgersia sambucifolia and other botanicals. It is indicated for acute diarrhea, especially in children with symptoms attributed to spleen and stomach qi deficiency or indigestion. Pharmacological studies have demonstrated antidiarrheal effects in animal models, likely through mechanisms involving modulation of gut microbiota and anti-inflammatory actions[1][2][7]. The product has been developed into a proprietary powder formulation by China Shineway Pharmaceutical Group Limited and is undergoing clinical research as a first-line therapy for pediatric acute diarrhea[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sechang Zhixie Powder.